Chen Q, Huo K, Ji S, Pang S, Sun T, Niu Y
Bioeng Transl Med. 2025; 10(2):e10713.
PMID: 40060761
PMC: 11883111.
DOI: 10.1002/btm2.10713.
Li J, Liu D, Li X, Wei J, Du W, Zhao A
Hum Vaccin Immunother. 2025; 21(1):2469333.
PMID: 40013818
PMC: 11869779.
DOI: 10.1080/21645515.2025.2469333.
Boomgarden A, Upadhyay C
Vaccines (Basel). 2025; 13(2).
PMID: 40006695
PMC: 11860913.
DOI: 10.3390/vaccines13020148.
Otgaar T, Bernert M, Morris G, Baichan P, Bignoux M, Letsolo B
Cell Mol Life Sci. 2025; 82(1):83.
PMID: 39985566
PMC: 11846807.
DOI: 10.1007/s00018-025-05593-0.
Welbourne E, Copley R, Owen G, Evans C, Isoko K, Cook K
Analyst. 2025; 150(5):1012-1021.
PMID: 39928146
PMC: 11809621.
DOI: 10.1039/d5an00033e.
Nucleic acid therapeutics: Past, present, and future.
Naeem S, Zhang J, Zhang Y, Wang Y
Mol Ther Nucleic Acids. 2025; 36(1):102440.
PMID: 39897578
PMC: 11786870.
DOI: 10.1016/j.omtn.2024.102440.
Synthesizing unmodified, supercoiled circular DNA molecules .
Rezaei S, Moncada-Restrepo M, Leng S, Chambers J, Leng F
bioRxiv. 2025; .
PMID: 39896529
PMC: 11785245.
DOI: 10.1101/2025.01.24.634800.
mRNA therapy: a precise and efficient approach for disease treatment.
Zhou J, Yang Y
Life Med. 2025; 3(4):lnae035.
PMID: 39872861
PMC: 11748992.
DOI: 10.1093/lifemedi/lnae035.
Advances in RNA-Based Therapeutics: Challenges and Innovations in RNA Delivery Systems.
Liu Y, Ou Y, Hou L
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852137
PMC: 11763986.
DOI: 10.3390/cimb47010022.
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future.
Bello M, Alsaadi A, Naeem A, Almahboub S, Bosaeed M, Aljedani S
Front Immunol. 2025; 15():1475886.
PMID: 39840044
PMC: 11747009.
DOI: 10.3389/fimmu.2024.1475886.
Advances in nucleic acid-based cancer vaccines.
Liao H, Liu S
J Biomed Sci. 2025; 32(1):10.
PMID: 39833784
PMC: 11748563.
DOI: 10.1186/s12929-024-01102-w.
Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.
Araujo Cirne C, Foldvari M
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025; 17(1):e70000.
PMID: 39800783
PMC: 11725562.
DOI: 10.1002/wnan.70000.
Efficient gene delivery admitted by small metabolites specifically targeting astrocytes in the mouse brain.
Zhou H, Dai J, Li D, Wang L, Ye M, Hu X
Mol Ther. 2025; 33(3):1166-1179.
PMID: 39799395
PMC: 11897751.
DOI: 10.1016/j.ymthe.2025.01.006.
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases.
Brandi R, Paganelli A, DAmelio R, Giuliani P, Lista F, Salemi S
Vaccines (Basel). 2025; 12(12.
PMID: 39772079
PMC: 11680146.
DOI: 10.3390/vaccines12121418.
mRNA vaccines in the context of cancer treatment: from concept to application.
Fu Q, Zhao X, Hu J, Jiao Y, Yan Y, Pan X
J Transl Med. 2025; 23(1):12.
PMID: 39762875
PMC: 11702060.
DOI: 10.1186/s12967-024-06033-6.
Nonviral targeted mRNA delivery: principles, progresses, and challenges.
He X, Li G, Huang L, Shi H, Zhong S, Zhao S
MedComm (2020). 2025; 6(1):e70035.
PMID: 39760110
PMC: 11695212.
DOI: 10.1002/mco2.70035.
Orthogonal RNA replication enables directed evolution and Darwinian adaptation in mammalian cells.
Ma L, Lin Y
Nat Chem Biol. 2025; 21(3):451-463.
PMID: 39753704
DOI: 10.1038/s41589-024-01783-2.
Understanding the pathogenicity of Naegleria fowleri in association with N. fowleri antigen-1 (Nfa1).
Kim J, Sohn H, Shin H, Walz S, Jung S
Parasites Hosts Dis. 2024; 62(4):385-398.
PMID: 39622651
PMC: 11614482.
DOI: 10.3347/PHD.24025.
Nucleic acid drugs: recent progress and future perspectives.
Sun X, Setrerrahmane S, Li C, Hu J, Xu H
Signal Transduct Target Ther. 2024; 9(1):316.
PMID: 39609384
PMC: 11604671.
DOI: 10.1038/s41392-024-02035-4.
Recent Advances and Prospects in RNA Drug Development.
Tani H
Int J Mol Sci. 2024; 25(22).
PMID: 39596348
PMC: 11594839.
DOI: 10.3390/ijms252212284.